» Articles » PMID: 38540712

TRPV Channels in Osteoarthritis: A Comprehensive Review

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 Mar 28
PMID 38540712
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is a debilitating joint disorder that affects millions of people worldwide. Despite its prevalence, our understanding of the underlying mechanisms remains incomplete. In recent years, transient receptor potential vanilloid (TRPV) channels have emerged as key players in OA pathogenesis. This review provides an in-depth exploration of the role of the TRPV pathway in OA, encompassing its involvement in pain perception, inflammation, and mechanotransduction. Furthermore, we discuss the latest research findings, potential therapeutic strategies, and future directions in the field, shedding light on the multifaceted nature of TRPV channels in OA.

Citing Articles

The contribution of clock genes BMAL1 and PER2 in osteoarthritis-associated pain.

Rodriguez-Palma E, Loya-Lopez S, Allen K, Cruz-Almeida Y, Khanna R Neurobiol Pain. 2025; 17():100177.

PMID: 39850977 PMC: 11754085. DOI: 10.1016/j.ynpai.2024.100177.


Recent Advances in Hydrogel Technology in Delivering Mesenchymal Stem Cell for Osteoarthritis Therapy.

Wang X, He W, Huang H, Han J, Wang R, Li H Biomolecules. 2024; 14(7).

PMID: 39062572 PMC: 11274544. DOI: 10.3390/biom14070858.

References
1.
Kark T, Bagi Z, Lizanecz E, Pasztor E, Erdei N, Czikora A . Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1. Mol Pharmacol. 2008; 73(5):1405-12. DOI: 10.1124/mol.107.043323. View

2.
Aguettaz E, Bois P, Cognard C, Sebille S . Stretch-activated TRPV2 channels: Role in mediating cardiopathies. Prog Biophys Mol Biol. 2017; 130(Pt B):273-280. DOI: 10.1016/j.pbiomolbio.2017.05.007. View

3.
Iftinca M, Defaye M, Altier C . TRPV1-Targeted Drugs in Development for Human Pain Conditions. Drugs. 2020; 81(1):7-27. DOI: 10.1007/s40265-020-01429-2. View

4.
Koch S, Gao X, Haar L, Jiang M, Lasko V, Robbins N . Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation. J Mol Cell Cardiol. 2012; 53(1):134-44. PMC: 3372642. DOI: 10.1016/j.yjmcc.2012.04.011. View

5.
Gu Y, Chen J, Meng Z, Ge W, Bian Y, Cheng S . Research progress on osteoarthritis treatment mechanisms. Biomed Pharmacother. 2017; 93:1246-1252. DOI: 10.1016/j.biopha.2017.07.034. View